Btim »

Halozyme Therapeutics shares owned by Btim

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Btim from 13F filings

Historical chart of Btim investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Btim consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Btim

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 683k 57.24
2024-06-30 $23M 443k 52.36

More positions owned by Btim

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-a Common Stock (GOOGL)
Aptargroup Common Stock (ATR)
Jpmorgan Chase & Co Common Stock (JPM)
Accenture Plc-cl A Common Stock (ACN)
Alphabet Inc-cl C Common Stock (GOOG)
Donaldson Common Stock (DCI)
Visa Common Stock (V)
Johnson & Johnson Common Stock (JNJ)
United Health Group Common Stock (UNH)
Waters Corp Common Stock (WAT)
Automatic Data Processing Common Stock (ADP)
Costco Wholesale Corp Common Stock (COST)
Cooper Cos Inc/the Common Stock (COO)

View all positions for Btim

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics